COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,864 Articles (22,568 medRxiv, 8,296 bioRxiv)

Most recent first Previous |  Page 2023: Articles 20221-20230  | Next

Chest CT features of COVID-19 in the region of Abu Dhabi, UAE- A single institute study
Saeed, G., Al Helali, A., Almazrouei, S., Shah, A., Ahmed, L.
10.1101/2020.11.14.20229096 — Posted: 2020-11-16
No evidence of increase in suicide in Greece during the first wave of Covid-19
Vandoros, S., Theodorikakou, O., Katsadoros, K., Zafeiropoulou, D., Kawachi, I.
10.1101/2020.11.13.20231571 — Posted: 2020-11-16
Electrocardiographic Abnormalities and Troponin Elevation in COVID-19
Chorin, E., Dai, M., Kogan, E., Wadhwani, L., Shulman, E., Nadeau-Routhier, C., Knotts, R., Bar-Cohen, R., Barbhaiya, C., Aizer, A., Holmes, D., Bernstein, S., Spinelli, M., Park, D., Chinitz, L., Jankelosn, L.
10.1101/2020.11.12.20230565 — Posted: 2020-11-16
COVID-19 vaccine hesitancy and resistance: Correlates in a nationally representative longitudinal survey of the Australian population
Edwards, B., Biddle, N., Gray, M., Sollis, K.
10.1101/2020.11.13.20231480 — Posted: 2020-11-16
Wastewater-based Epidemiology for Averting COVID-19 Outbreaks on The University of Arizona Campus
Betancourt, W. W., Schmitz, B. W., Innes, G. K., Pogreba Brown, K. M., Prasek, S. M., Stark, E. R., Foster, A. R., Sprissler, R. S., Harris, D. T., Sherchan, S. P., Gerba, C. P., Pepper, I. L.
10.1101/2020.11.13.20231340 — Posted: 2020-11-16
Prediction of Covid-19 Infections Through December 2020 for 10 US States Incorporating Outdoor Temperature and School Re-Opening Effects-October Update
Newell, T. A.
10.1101/2020.11.14.20231902 — Posted: 2020-11-16
The occurrence of cardiovascular complications associated with SARS-CoV-2 infection: a systematic review
Sardinha, D. M., Lima, K. V., Ueno, T. M., Rodrigues, Y. C., Garcez, J. C., Santos, A. L., Ferreira, A. L., Guimaraes, R. J., Lima, L. N.
10.1101/2020.11.14.20231803 — Posted: 2020-11-16
Assessment of functional capacity with cardiopulmonary exercise testing in non-severe COVID-19 patients at three months follow-up
Clavario, P., De Marzo, V., Lotti, R., Barbara, C., Porcile, A., Russo, C., Beccaria, F., Bonavia, M., Bottaro, L. C., Caltabellotta, M., Chioni, F., Santangelo, M., Hautala, A., Ameri, P., Canepa, M., Porto, I.
10.1101/2020.11.15.20231985 — Posted: 2020-11-16
Dysregulated immunity in SARS-CoV-2 infected pregnant women
Sherer, M. L., Lei, J., Creisher, P., Jang, M., Reddy, R., Voegtline, K., Olson, S., Littlefield, K., Park, H.-S., Ursin, R. L., Ganesan, A., Boyer, T., Brown, D. M., Walch, S., Antar, A. A. R., Manabe, Y. C., Jones-Beatty, K., Golden, W. C., Satin, A. J., Sheffield, J. S., Pekosz, A., Klein, S., Burd, I.
10.1101/2020.11.13.20231373 — Posted: 2020-11-16
Lack of immune homology with vaccine preventable pathogens suggests childhood immunizations do not protect against SARS-CoV-2 through adaptive cross-immunity
Guo, W., Lee, K. O., Lee, P. P.
10.1101/2020.11.13.20230862 — Posted: 2020-11-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).